TNFRSF10A antibody
Quick Overview for TNFRSF10A antibody (ABIN1383733)
Target
See all TNFRSF10A AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognises a 43-46 kDa protein
-
Purification
- Ion exchange chromatography
-
Sterility
- 0.22 μm filtered
-
Immunogen
- Recombinant human TRAIL R1/Fc chimera,Myeloma X63/AG.8653 x Balb/c spleen cells
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
Preservative
- Without preservative
-
Storage
- 4 °C
-
Storage Comment
- Stable at +2-8°C for 12 months
-
-
-
: "CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells." in: Cancer research, Vol. 68, Issue 13, pp. 5335-44, (2008) (PubMed).
: "The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis." in: Molecular cancer therapeutics, Vol. 7, Issue 7, pp. 2212-23, (2008) (PubMed).
: "CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of ..." in: Molecular pharmacology, Vol. 72, Issue 5, pp. 1269-79, (2007) (PubMed).
: "Characterization of monoclonal antibodies directed against trail or trail receptors." in: Cellular immunology, Vol. 236, Issue 1-2, pp. 86-91, (2005) (PubMed).
-
-
- TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))
-
Alternative Name
- TRAIL R1
-
Background
- DR4, TRAIL R1
-
Molecular Weight
- 43-46 kDa
-
Pathways
- Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-